Literature DB >> 29353193

Automated radiosynthesis of Al[18F]PSMA-11 for large scale routine use.

Ken Kersemans1, Kathia De Man2, Jan Courtyn2, Tessa Van Royen3, Sarah Piron3, Lieselotte Moerman2, Boudewijn Brans2, Filip De Vos3.   

Abstract

OBJECTIVES: We report a reproducible automated radiosynthesis for large scale batch production of clinical grade Al[18F]PSMA-11.
METHODS: A SynthraFCHOL module was optimized to synthesize Al[18F]PSMA-11 by Al[18F]-chelation. Results Al[18F]PSMA-11 was synthesized within 35min in a yield of 21 ± 3% (24.0 ± 6.0GBq) and a radiochemical purity > 95%. Batches were stable for 4h and conform the European Pharmacopeia guidelines.
CONCLUSIONS: The automated synthesis of Al[18F]PSMA-11 allows for large scale production and distribution of Al[18F]PSMA-11.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AlF(2+); Automation; Chelation; PSMA; Prostate cancer

Year:  2018        PMID: 29353193     DOI: 10.1016/j.apradiso.2018.01.006

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  9 in total

1.  Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform.

Authors:  Javier Giglio; Maia Zeni; Eduardo Savio; Henry Engler
Journal:  EJNMMI Radiopharm Chem       Date:  2018-02-27

Review 2.  The Search for an Alternative to [68Ga]Ga-DOTA-TATE in Neuroendocrine Tumor Theranostics: Current State of 18F-labeled Somatostatin Analog Development.

Authors:  Christopher M Waldmann; Andreea D Stuparu; R Michael van Dam; Roger Slavik
Journal:  Theranostics       Date:  2019-02-14       Impact factor: 11.556

Review 3.  A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling?

Authors:  Cyril Fersing; Ahlem Bouhlel; Christophe Cantelli; Philippe Garrigue; Vincent Lisowski; Benjamin Guillet
Journal:  Molecules       Date:  2019-08-07       Impact factor: 4.411

Review 4.  Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology.

Authors:  Christine Rangger; Roland Haubner
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-30

5.  Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice.

Authors:  Sarah Piron; Jeroen Verhoeven; Benedicte Descamps; Ken Kersemans; Kathia De Man; Nick Van Laeken; Leen Pieters; Anne Vral; Christian Vanhove; Filip De Vos
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

6.  Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer.

Authors:  Sarah Piron; Jeroen Verhoeven; Emma De Coster; Benedicte Descamps; Ken Kersemans; Leen Pieters; Anne Vral; Christian Vanhove; Filip De Vos
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

7.  Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors.

Authors:  Sarah Piron; Jeroen Verhoeven; Jan Courtyn; Ken Kersemans; Benedicte Descamps; Leen Pieters; Anne Vral; Christian Vanhove; Filip De Vos
Journal:  Sci Rep       Date:  2022-09-21       Impact factor: 4.996

8.  Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer.

Authors:  Sarah Piron; Kathia De Man; Vanessa Schelfhout; Nick Van Laeken; Ken Kersemans; Eric Achten; Filip De Vos; Piet Ost
Journal:  EJNMMI Res       Date:  2020-02-24       Impact factor: 3.138

Review 9.  18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging.

Authors:  Rudolf A Werner; Thorsten Derlin; Constantin Lapa; Sara Sheikbahaei; Takahiro Higuchi; Frederik L Giesel; Spencer Behr; Alexander Drzezga; Hiroyuki Kimura; Andreas K Buck; Frank M Bengel; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.